Skip to main content

REVIEW article

Front. Neurol.
Sec. Movement Disorders
Volume 15 - 2024 | doi: 10.3389/fneur.2024.1470928
This article is part of the Research Topic The Neuroscience of Parkinson's Disease: Exploring Causes, Symptoms, and Potential Treatments View all 6 articles

Commercial Symptom Monitoring Devices in Parkinson's Disease: Benefits, Limitations, and Trends

Provisionally accepted
Daniel Rodriguez Daniel Rodriguez 1Carlos Pérez Carlos Pérez 2*
  • 1 Sense4Care, Cornellà de Llobregat, Spain
  • 2 Consorci Sanitari del Garraf (CSG), Sant Pere de Ribes, Spain

The final, formatted version of the article will be published soon.

    Parkinson's disease (PD) is a neurodegenerative disorder that significantly impacts patients' quality of life. Managing PD requires accurate assessment of motor and non-motor symptoms, often complicated by the subjectivity in symptom reporting and the limited availability of neurologists. To address these challenges, commercial wearable devices have emerged to continuously monitor PD symptoms outside the clinical setting. The main devices include PKG™, Kinesia 360™, Kinesia U™, PDMonitor™, and STAT-ON™. These devices utilize advanced technologies such as accelerometers, gyroscopes, and specific algorithms to provide objective data on motor symptoms like tremors, dyskinesia, and bradykinesia. Despite their potential, the adoption of these devices is limited due to concerns about their accuracy, complexity of use, and lack of independent validation. The correlation between these devices' measurements and traditional clinical observations varies, and patient usability and adherence remain critical areas for improvement. To optimize their utility and improve patient outcomes, it is essential to conduct validation and usability studies with a sufficient number of patients, develop standardized protocols, and ensure integration with hospital information systems.

    Keywords: wearables, Motor symptoms, Early detection, medical devices, Objective evaluation

    Received: 26 Jul 2024; Accepted: 09 Dec 2024.

    Copyright: © 2024 Rodriguez and Pérez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Carlos Pérez, Consorci Sanitari del Garraf (CSG), Sant Pere de Ribes, Spain

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.